Population Health Management Market Size, Trends, Share, Growth | Report 2022-2030
The global population health management market was estimated at USD 47.4 billion in 2021 and it is expected to surpass around USD 280.9 billion by 2030, poised to grow at a CAGR of 21.86% from 2022 to 2030.
The need for population health services that combine multiple functionalities is increasing due to the complex nature of care delivery and payment models. Population Health Management (PHM) solutions can process clinical, financial, and operational data that help improve efficiency and patient care. The health management program is also witnessing changes in medical reimbursement due to the increasing emphasis on value-based payment models and Accountable Care Organizations (ACOs).
The COVID-19 pandemic has intensified the need for social distance among physicians and other healthcare workers, driving the need for population health management solutions and the correct and timely transmission of patient health information and claims data for patients with chronic diseases. PHM provides effective tools in this regard, including a framework for the secure transmission, sharing, and retrieval of electronic health information and claims data. For clinical and financial decision-making, these technologies enable the smooth transmission and analysis of health-related data between healthcare institutions and patients.
Furthermore, as patient numbers increase, so does the requirement for electronic medical records and electronic health record solutions to manage complicated patient data. Players in this market have also connected the electronic health record platforms with other IT solutions such as population health management and enhanced their software solutions to assist healthcare practitioners in efficiently managing COVID-19 patients. The convenience offered by value-based payment models is responsible for the increased adoption of population health solutions by ACOs.
ACOs, consisting of hospitals, clinics, and other healthcare providers, collaborate with the payers (private and public) to provide high-quality care to the patients. Private and public insurance providers have introduced various disease management programs that help in the treatment of chronic illnesses. These multidisciplinary efforts are expected to result in efficient treatment outcomes and are likely to suggest the best suitable courses of action that need to be undertaken. Successful large-scale trials in the U.S. have enabled significant advancements in disease management programs.
Most healthcare providers worldwide have insufficient infrastructure, including health professionals, patients’ data, technology, and other resources to manage healthcare issues. To manage a large population, suppliers must invest considerably in infrastructure development. The government's expanded monitoring support for healthcare IT systems, as well as the rising use of big data analytics and the need to contain expanding healthcare costs, would all fuel the expansion of the population health management industry.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 47.4 billion |
| Revenue Forecast by 2030 | USD 280.9 billion |
| Growth rate from 2022 to 2030 | CAGR of 21.86% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, end use, region |
| Companies Covered | Allscripts; McKesson Corporation; Cerner Corporation; Conifer Health Solutions LLC; eClinicalWorks |
Product Insights
The services segment dominated the market for population health management and accounted for the largest revenue share of more than 51.0% in 2021. Growing preference for in-house systems in hospitals and other care providers to avoid involving third parties to assess patient data is driving the services segment. The rising need for integrated healthcare systems is also responsible for the increasing demand for PHM.
As healthcare costs are increasing, manufacturers are investing in research and development to launch innovative products to help healthcare organizations. For instance, in October 2020, Allscripts announced its agreement of selling the CarePort Health business to WellSky Corp. for an upfront payment of USD 1.35 billion, and in June 2019, Health Catalyst, Inc. announced the launch of its Population Health Foundations solution. The product includes DOS Marts, Excel-friendly Analysis Tools, Population Builder: Stratification Module, Leading Wisely: Population Health, and Community Care as its technology components and PHM Solution Optimization and PHM Opportunity Analysis as its service components.
End-use Insights
The healthcare providers segment dominated the market for population health management and accounted for a revenue share of 48.7% in 2021. PHM improves clinical outcomes by aiding in better disease management, resulting in reduced in-patient stay and overall observation hours of physicians. Hence, providers can focus more on patient-centric care and reduce overall costs.
Payers are the third-party entities that finance or reimburse the cost of health services. Predictive analytics competency gives payers an advantage over other providers in interpreting population behavior and unstructured clinical content. This competitive advantage is instrumental in increasing the demand for PHM software for payers and is expected to propel segment growth significantly over the forecast period.
Regional Insights
North America dominated the population health management market and accounted for a revenue share of 46.9% in 2021. Total healthcare spending in the U.S. is expected to reach up to USD 4.8 trillion in 2021, accounting for nearly 20% of Gross Domestic Product (GDP) by 2021. Thus, the alarming increase in healthcare costs is, in turn, escalating the demand for an effective PHM. The government is focusing on increased incentives and investments to improve national health by accurately tracking the health of the population and its subgroups. The factors, such as pressure on the healthcare industry to reduce medical costs, rising use of information technology in healthcare, cloud computing, regulatory scenario, and increasing diseases are driving the market for population health management in North America.
For instance, the U.S. government implemented the ACA which is the Affordable Care Act for the prevention of diseases, and the adoption of IT in healthcare, this will boost the market growth and create opportunities for the service provider to effectively collect and maintain patients' data. In Asia Pacific, the market for population health management is anticipated to experience the fastest growth over the forecast period due to improving healthcare infrastructure and rising healthcare expenditure. Furthermore, the incidence of chronic diseases is expected to double from 2001 to 2025 in the Asia Pacific region. Managing the data generated from this increase will require advanced data analytics, which is expected to boost the growth of the market for population health management in the region.
Key Players
Market Segmentation
Chapter 1.Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2.Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3.Executive Summary
3.1.Market Snapshot
Chapter 4.Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1.Raw Material Procurement Analysis
4.3.2.Sales and Distribution Channel Analysis
4.3.3.Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on Population Health Management Market
5.1.COVID-19 Landscape: Population Health Management Industry Impact
5.2.COVID 19 - Impact Assessment for the Industry
5.3.COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6.Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1.Market Drivers
6.1.2.Market Restraints
6.1.3.Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1.Bargaining power of suppliers
6.2.2.Bargaining power of buyers
6.2.3.Threat of substitute
6.2.4.Threat of new entrants
6.2.5.Degree of competition
Chapter 7.Competitive Landscape
7.1.1.Company Market Share/Positioning Analysis
7.1.2.Key Strategies Adopted by Players
7.1.3.Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8.Global Population Health Management Market, By Product
8.1.Population Health Management Market, by Product Type, 2022-2030
8.1.1.Software
8.1.1.1.Market Revenue and Forecast (2017-2030)
8.1.2.Services
8.1.2.1.Market Revenue and Forecast (2017-2030)
Chapter 9.Global Population Health Management Market, By End-use
9.1.Population Health Management Market, by End-use, 2022-2030
9.1.1.Payers
9.1.1.1.Market Revenue and Forecast (2017-2030)
9.1.2.Providers
9.1.2.1.Market Revenue and Forecast (2017-2030)
9.1.3.Employer Groups
9.1.3.1.Market Revenue and Forecast (2017-2030)
Chapter 10.Global Population Health Management Market, Regional Estimates and Trend Forecast
10.1.North America
10.1.1.Market Revenue and Forecast, by Product (2017-2030)
10.1.2.Market Revenue and Forecast, by End-use (2017-2030)
10.1.3.U.S.
10.1.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.1.3.2.Market Revenue and Forecast, by End-use (2017-2030)
10.1.4.Rest of North America
10.1.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2.Market Revenue and Forecast, by End-use (2017-2030)
10.2.Europe
10.2.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.2.Market Revenue and Forecast, by End-use (2017-2030)
10.2.3.UK
10.2.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.3.2.Market Revenue and Forecast, by End-use (2017-2030)
10.2.4.Germany
10.2.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2.Market Revenue and Forecast, by End-use (2017-2030)
10.2.5.France
10.2.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2.Market Revenue and Forecast, by End-use (2017-2030)
10.2.6.Rest of Europe
10.2.6.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2.Market Revenue and Forecast, by End-use (2017-2030)
10.3.APAC
10.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.2.Market Revenue and Forecast, by End-use (2017-2030)
10.3.3.India
10.3.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.3.2.Market Revenue and Forecast, by End-use (2017-2030)
10.3.4.China
10.3.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2.Market Revenue and Forecast, by End-use (2017-2030)
10.3.5.Japan
10.3.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2.Market Revenue and Forecast, by End-use (2017-2030)
10.3.6.Rest of APAC
10.3.6.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2.Market Revenue and Forecast, by End-use (2017-2030)
10.4.MEA
10.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.2.Market Revenue and Forecast, by End-use (2017-2030)
10.4.3.GCC
10.4.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.3.2.Market Revenue and Forecast, by End-use (2017-2030)
10.4.4.North Africa
10.4.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2.Market Revenue and Forecast, by End-use (2017-2030)
10.4.5.South Africa
10.4.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2.Market Revenue and Forecast, by End-use (2017-2030)
10.4.6.Rest of MEA
10.4.6.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2.Market Revenue and Forecast, by End-use (2017-2030)
10.5.Latin America
10.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.5.2.Market Revenue and Forecast, by End-use (2017-2030)
10.5.3.Brazil
10.5.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.5.3.2.Market Revenue and Forecast, by End-use (2017-2030)
10.5.4.Rest of LATAM
10.5.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2.Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11.Company Profiles
11.1.Allscripts
11.1.1.Company Overview
11.1.2.Product Offerings
11.1.3.Financial Performance
11.1.4.Recent Initiatives
11.2.McKesson Corporation
11.2.1.Company Overview
11.2.2.Product Offerings
11.2.3.Financial Performance
11.2.4.Recent Initiatives
11.3.Cerner Corporation
11.3.1.Company Overview
11.3.2.Product Offerings
11.3.3.Financial Performance
11.3.4.Recent Initiatives
11.4.Conifer Health Solutions LLC
11.4.1.Company Overview
11.4.2.Product Offerings
11.4.3.Financial Performance
11.4.4.Recent Initiatives
11.5.eClinicalWorks
11.5.1.Company Overview
11.5.2.Product Offerings
11.5.3.Financial Performance
11.5.4.Recent Initiatives
Chapter 12.Research Methodology
12.1.Primary Research
12.2.Secondary Research
12.3.Assumptions
Chapter 13.Appendix
13.1.About Us
13.2.Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers